Last $32.60 USD
Change Today +0.17 / 0.52%
Volume 68.0K
As of 8:10 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

orthofix international nv (OFIX) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/2/14 - $36.90
52 Week Low
03/3/14 - $21.99
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

orthofix international nv (OFIX) Related Businessweek News

No Related Businessweek News Found

orthofix international nv (OFIX) Details

Orthofix International N.V., a medical device company, designs, develops, manufactures, markets, and distributes medical devices used principally by musculoskeletal medical specialists for spine and orthopedic applications. The company operates in four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim segment offers a range of devices for use as adjunctive treatment to enhance fusion success in cervical and lumbar spine fusion, as well as a therapeutic treatment for non-healing fractures outside of the spine. The Biologics segment provides a portfolio of regenerative products that allow physicians to treat a range of spinal and orthopedic conditions under the Trinity Evolution and Trinity Elite names. The Extremity Fixation segment offers orthopedic products used in fracture repair, deformity correction, and bone reconstruction. The Spine Fixation segment provides a range of implant products used in surgical procedures of the spine. The company markets and distributes its products directly to hospitals, doctors, and other healthcare providers in the United States, the United Kingdom, Italy, Germany, Switzerland, Austria, France, Belgium, Brazil, Australia, and Puerto Rico, as well as through independent distributors, sales representatives, and affiliates in other markets. Orthofix International N.V. was founded in 1987 and is headquartered in Willemstad, Curaçao.

889 Employees
Last Reported Date: 03/31/14
Founded in 1987

orthofix international nv (OFIX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $452.8K
President of Global Extremity Fixation
Total Annual Compensation: $437.2K
Chief Strategy Officer
Total Annual Compensation: $460.0K
Chief Administrative Officer, General Counsel...
Total Annual Compensation: $455.0K
Compensation as of Fiscal Year 2013.

orthofix international nv (OFIX) Key Developments

NASDAQ Hearing Panel Grants Additional Time To Orthofix International To Complete The Late Reports And The Further Restatement

As previously disclosed, Orthofix International N.V. recently requested an additional extension from a Nasdaq Hearings Panel (Hearings Panel) to permit additional time for the Company to complete the Late Reports and the Further Restatement. On January 15, 2015, the Company received notice from NASDAQ’s Office of General Counsel that the Hearings Panel has granted the Company continued listing through March 31, 2015, conditioned upon the Company being current in its filing obligations with the Securities and Exchange Commission (the “SEC”) as of such date (including by having filed with the SEC on or prior to such date the Late Reports and the amended reports containing the Further Restatement).

Orthofix International N.V. Provides Sales Guidance for the Year 2014

Orthofix International N.V. provided that its full year 2014 net sales is expected to be in a range of approximately $397 million and $401 million.

Orthofix International Provides Update Regarding NASDAQ Listing Matters

As previously disclosed, Orthofix International N.V. participated in a hearing before a NASDAQ Hearings Panel on October 2, 2014 in connection with the Company’s non-compliance with NASDAQ Listing Rule 5250(c)(1) due to the delayed filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2014, and the Company’s anticipated financial restatement relating to prior periods. At the hearing, the Company requested that the Hearings Panel grant the Company through January 15, 2015 to make these filings, as well as the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2014, though the 2014 Third Quarter Form 10-Q was not yet due as of the hearing date under the rules of the Securities and Exchange Commission. On October 9, 2014, the Company received a decision letter from NASDAQ’s Office of General Counsel stating that the Hearings Panel had granted the Company’s request and, accordingly, the Company’s common stock would continue to trade on the NASDAQ Stock Market provided that the Company becomes current in its periodic filings with the SEC on or before January 15, 2015. On November 19, 2014, the Company received an anticipated letter from NASDAQ noting that the 2014 Third Quarter Form 10-Q had not been filed by its due date with the SEC on November 10, 2014 and, as such, represented an additional basis for non-compliance with Listing Rule 5250(c)(1). The Company continues to work to complete the procedures needed to file its two delayed quarterly reports, as well as the amended reports containing its restatement for prior periods. As requested by the letter from NASDAQ, the Company will be providing a written update to the Hearings Panel regarding these matters on November 25, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OFIX:US $32.60 USD +0.17

OFIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $18.89 USD +0.29
Merit Medical Systems Inc $19.74 USD +0.13
NxStage Medical Inc $17.09 USD -0.09
RTI Surgical Inc $5.42 USD +0.10
Tornier NV $24.61 USD +0.17
View Industry Companies

Industry Analysis


Industry Average

Valuation OFIX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.5x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORTHOFIX INTERNATIONAL NV, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at